InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,555.74
(
-0.16%
)
US TECH 100
19,107.20
(
-1.02%
)
Dow Jones
40,358.09
(
-0.14%
)
Brent Oil
80.62
(
-0.20%
)
Bitcoin
65,981.32
(
0.09%
)
Post# of 12660
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

walldiver

Send PM Follow Ignore
Followers 24
Posts 1614
Boards Moderated 0
Alias Born 01/02/2003

walldiver

Re: io_io post# 2429

Thursday, 03/29/2007 7:14:23 PM

Thursday, March 29, 2007 7:14:23 PM

Post# of 12660
Not formally...but both Mule and Dubinett emphasized that they believed the panel members should be flexible and vote Yes with 9902B stipulation. Witten on Marketwatch just said that FDA was looking for guidance on the survival benefit, and also expects results of 9902B in 2010. To me, this indicates there is no way the FDA will wait for 9902B survival to approve.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up